An inconsistent association of higher BCL2 expression with the non-GCB subtype has been reported in systemic DLBCL, and BCL2 expression has been associated with translocations or amplifications involving chromosome 18q21, the locus of BCL2[10], [42]. The gene discussed is BCL2; the disease is diffuse large B-cell lymphoma.